When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.
about
When to perform bone scintigraphy in patients with newly diagnosed prostate cancer? a retrospective studyConsequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey.Application of bone scans for prostate cancer staging: Which guideline shows better result?Is there a role of whole-body bone scan in patients with esophageal squamous cell carcinoma.Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy.Updated trends in imaging use in men diagnosed with prostate cancer.Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?A Population-Based Study on the Association between Benign Prostatic Enlargement and Rheumatoid Arthritis.Adherence to Guidelines among Italian Urologists on Imaging Preoperative Staging of Low-Risk Prostate Cancer: Results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study.Toward better use of bone scans among men with early-stage prostate cancerOptimal bone health management strategies in patients with prostate cancerThree-minute SPECT/CT is sufficient for the assessment of bone metastasis as add-on to planar bone scintigraphy: prospective head-to-head comparison to 11-min SPECT/CT.Imaging and evaluation of patients with high-risk prostate cancer.Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons.Prostatic metastases and polycythemia vera on bone magnetic resonance imaging: A case report.Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study.Changing the referral criteria for bone scan in newly diagnosed prostate cancer patients.Does T1- and diffusion-weighted magnetic resonance imaging give value-added than bone scintigraphy in the follow-up of vertebral metastasis of prostate cancer?Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?Are staging investigations being overused in patients with low and intermediate risk prostate cancer?Is there still a role for computed tomography and bone scintigraphy in prostate cancer staging? An analysis from the EUREKA-1 database.Diagnostic test accuracy study of 18F-sodium fluoride PET/CT, 99mTc-labelled diphosphonate SPECT/CT, and planar bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancer.Cost of illness of metastatic prostate cancer: a perspective of costs for new treatment options in The Netherlands.Establishing the pathways and indications for performing isotope bone scans in newly diagnosed intermediate-risk localised prostate cancer - results from a large contemporaneous cohort.Consensus statements on the management of metastatic prostate cancer from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.Validation of contemporary guidelines for bone scintigraphy in prostate cancer staging: A prospective study in patients undergoing radical prostatectomy.Reporting and Handling of Indeterminate Bone Scan Results in the Staging of Prostate Cancer: A Systematic Review.18-Fluoride labeled sodium fluoride positron emission tomography with computer tomography: the impact of pretreatment staging in intermediate- and high-risk prostate cancer.The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer.Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital-based analysis of patterns of care, RT fractionation scheme, and overall survival
P2860
Q33791760-2FCA54E8-D3C4-4625-B830-4032BFB3DF00Q34040036-19666C68-A23E-426F-BB8A-7C73033813B9Q34062444-62BDC35A-0C15-4650-A34B-1A5997A01E69Q34361948-0D3176E9-7075-44A9-B628-2F897724160BQ34383010-E78E0CF9-BD83-47B3-B6C6-02BEB267BD5DQ34704662-8C2F8AC3-8A4B-4607-8D0E-086CD56DFC0BQ35372874-C632026B-9C2E-4EC9-A105-05E2FED4E06AQ35690602-3EEB0B61-A155-4D86-8C7D-F985C0510170Q35990762-707F8FB3-4378-4A79-B6E2-DA1344860C1AQ36585253-7AE8CF89-AE2E-4D78-BB69-D486D1E106D0Q37080734-6E975F16-488A-444F-AD3B-37DD75B3C78CQ37562219-FCFEBB92-75E0-42DC-BDAA-EC060CDF82B5Q38611187-F817B038-866B-4074-9D7B-63205C873623Q38766102-C1C516A1-D33F-4707-A282-1826BA5388F4Q39041834-A4485229-7FA8-4668-B91B-5BAFBEC4794AQ39963882-B4D5C742-59D8-4D43-B86C-D960D62E62D2Q41565897-469C72CF-3B21-4FD5-A811-A307BAC1881CQ41566010-23C3585C-B256-4CD5-913D-5FCFC853F8FEQ42554415-DEBEC575-D363-4398-8D86-C7A185672CB7Q43977098-9160BBB1-DFCB-4FA3-B678-209D70F29D8AQ46696128-573130A7-7C54-4E10-A928-920C062BC260Q47136477-1D1A7121-A96F-4EC6-922B-199AC71A6A9DQ47678023-313C22B1-05EF-450B-866E-2097F456ACD0Q48105677-A92F1B69-C0FB-4C16-90E7-61BE227E36D0Q48167919-EC2632AC-210F-4C75-AB15-37BE4F5540CEQ48952907-D3DB7EDA-09FC-4EF7-A621-DFA8A4E4C282Q50027134-9C70E44C-74FA-4010-AD6F-80123823131CQ55165433-A22C9E1B-1741-43E0-B6D4-69CD3AD3BBE9Q55402337-962D32D3-4C8C-460C-B636-1E02D9DDC50BQ58767681-691EE76A-B0E8-4B02-A483-726CD8FD5D6F
P2860
When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
When to perform bone scan in p ...... ovel risk stratification tool.
@en
When to perform bone scan in p ...... ovel risk stratification tool.
@nl
type
label
When to perform bone scan in p ...... ovel risk stratification tool.
@en
When to perform bone scan in p ...... ovel risk stratification tool.
@nl
prefLabel
When to perform bone scan in p ...... ovel risk stratification tool.
@en
When to perform bone scan in p ...... ovel risk stratification tool.
@nl
P2093
P50
P1433
P1476
When to perform bone scan in p ...... ovel risk stratification tool.
@en
P2093
Andrea Salonia
Cristina Messa
Liugi Gianolli
Luigi Filippo Da Pozzo
Matteo Ferrari
Nazareno Suardi
Niccolò Passoni
Patrizio Rigatti
Valerio Di Girolamo
P304
P356
10.1016/J.EURURO.2009.12.023
P407
P577
2009-12-18T00:00:00Z